UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Nasopharyngeal Carcinoma: From Etiology to Clinical Practice

1, 2019

Link zum Volltext

Verfügbarkeit prüfen

Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis ?

Journal of clinical oncology, 2022-04, Vol.40 (11), p.1135-1138

2022

Link zum Volltext

Verfügbarkeit prüfen

In Reply to Abbasi et al

International journal of radiation oncology, biology, physics, 2022-01, Vol.112 (1), p.262-263

2022

Link zum Volltext

Verfügbarkeit prüfen

Late Toxicities after Conventional Radiotherapy for Nasopharyngeal Carcinoma: Incidence and Risk Factors

Journal of Radiotherapy, 2014-02, Vol.2014, p.1-8

2014

Link zum Volltext

Verfügbarkeit prüfen

Optimizing Therapy: The Art and Science of Modern Head and Neck Radiation

International journal of radiation oncology, biology, physics, 2024-07, Vol.119 (3), p.709-715

2024

Link zum Volltext

Verfügbarkeit prüfen

Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer

Radiotherapy and oncology, 2024-07, Vol.196, p.110287-110287, Article 110287

2024

Link zum Volltext

Verfügbarkeit prüfen

Antitumor activity of bintrafusp alfa in previously treated patients with recurrent or metastatic nasopharyngeal cancer (NPC): A single arm, prospective phase II trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18029-e18029

2022

Link zum Volltext

Verfügbarkeit prüfen

Network-meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 8,221 patients

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6523-6523

2020

Link zum Volltext

Verfügbarkeit prüfen

IKBB tumor suppressive role in nasopharyngeal carcinoma via NF‐κB–mediated signalling

International journal of cancer, 2016-01, Vol.138 (1), p.160-170

2016

Link zum Volltext

Verfügbarkeit prüfen

Application of Artifcial Intelligence for Nasopharyngeal Carcinoma Management--A Systematic Review

Cancer management and research, 2022-01, Vol.14, p.339

2022

Link zum Volltext

Verfügbarkeit prüfen

Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in H ong K ong C hinese

International journal of cancer, 2018-11, Vol.143 (9), p.2289-2298

2018

Link zum Volltext

Verfügbarkeit prüfen

Disadvantaged Subgroups Within the Global Head and Neck Cancer Population: How Can We Optimize Care?

American Society of Clinical Oncology educational book, 2022-04, Vol.42 (42), p.1-510

2022

Link zum Volltext

Verfügbarkeit prüfen

Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinomaResearch in context

EBioMedicine, 2022-12, Vol.86, p.104357

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial

The Lancet regional health. Western Pacific, 2023-11, Vol.40, p.100898-100898, Article 100898

2023

Link zum Volltext

Verfügbarkeit prüfen

A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6002-6002

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trialResearch in context

The Lancet regional health. Western Pacific, 2023-11, Vol.40, p.100898

2023

Link zum Volltext

Verfügbarkeit prüfen

IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling: Tumor Suppressor IKBB in NPC

International journal of cancer, 2016-01, Vol.138 (1), p.160-170

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4148: Adverse effects of TERT-CLPTM1L and double-strand breaks repair contribute to risk for nasopharyngeal carcinoma

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4148-4148

2014

Link zum Volltext

Verfügbarkeit prüfen

Translational research in nasopharyngeal carcinoma : Nasopharyngeal Carcinoma

Oral oncology, 2014, Vol.50 (5), p.345-352

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4773: Aberrant methylation at chromosome 6p as novel biomarkers for diagnosis and prognosis of nasopharyngeal carcinoma

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4773-4773

2015

Link zum Volltext

Verfügbarkeit prüfen

NF-[kappa]B p65 Subunit Is Modulated by Latent Transforming Growth Factor-[beta] Binding Protein 2 in Nasopharyngeal Carcinoma HONE1 and HK1 Cells

PloS one, 2015-05, Vol.10 (5), p.e0127239

2015

Link zum Volltext

Verfügbarkeit prüfen

Whole-exome sequencing identifies multiple loss-of-function mutations of NF-[kappa]B pathway regulators in nasopharyngeal carcinoma

Proceedings of the National Academy of Sciences - PNAS, 2016-10, Vol.113 (40), p.11283

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1734: Preclinical study of HSP-90 inhibitor drug, AUY922 showed good efficacy in treatment of nasopharyngeal cancer

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1734-1734

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 730: Evaluation of micro-RNA biomarker panel on biopsies and non-invasive samples in nasopharyngeal carcinoma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.730-730

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

KollektionSpringer journals

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(43)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Nasopharyngeal Carcinoma
(9)
Humans
(5)
Nasopharyngeal Cancer
(4)
Aged
(3)
Female
(3)
Male
(3)
Adult
(2)
Bintrafusp Alfa
(2)
Cancer
(2)
Carcinoma
(2)
Chemotherapy
(2)
Correlative Biomarkers
(2)
Efficacy
(2)
Gastroenterology And Hepatology
(2)
Middle Aged
(2)
Nasopharyngeal Neoplasms
(2)
Nasopharyngeal Neoplasms - Pathology
(2)
Nasopharynx
(2)
Oncology
(2)
Prognosis
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Nasopharyngeal Carcinoma: From Etiology to Clinical Practice

Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis ?

In Reply to Abbasi et al

Late Toxicities after Conventional Radiotherapy for Nasopharyngeal Carcinoma: Incidence and Risk Factors

Optimizing Therapy: The Art and Science of Modern Head and Neck Radiation

Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer

Antitumor activity of bintrafusp alfa in previously treated patients with recurrent or metastatic nasopharyngeal cancer (NPC): A single arm, prospective phase II trial

Network-meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 8,221 patients

IKBB tumor suppressive role in nasopharyngeal carcinoma via NF‐κB–mediated signalling

Application of Artifcial Intelligence for Nasopharyngeal Carcinoma Management--A Systematic Review

Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in H ong K ong C hinese

Disadvantaged Subgroups Within the Global Head and Neck Cancer Population: How Can We Optimize Care?

Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinomaResearch in context

Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial

A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)

Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trialResearch in context

IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling: Tumor Suppressor IKBB in NPC

Abstract 4148: Adverse effects of TERT-CLPTM1L and double-strand breaks repair contribute to risk for nasopharyngeal carcinoma

Translational research in nasopharyngeal carcinoma : Nasopharyngeal Carcinoma

Abstract 4773: Aberrant methylation at chromosome 6p as novel biomarkers for diagnosis and prognosis of nasopharyngeal carcinoma

Prognostic nomogram for refining prognostication of the proposed AJCC/UICC 8th edition for nasopharyngeal cancer in the era of intensity-modulated radiotherapy

NF-[kappa]B p65 Subunit Is Modulated by Latent Transforming Growth Factor-[beta] Binding Protein 2 in Nasopharyngeal Carcinoma HONE1 and HK1 Cells

Whole-exome sequencing identifies multiple loss-of-function mutations of NF-[kappa]B pathway regulators in nasopharyngeal carcinoma

Abstract 1734: Preclinical study of HSP-90 inhibitor drug, AUY922 showed good efficacy in treatment of nasopharyngeal cancer

Abstract 730: Evaluation of micro-RNA biomarker panel on biopsies and non-invasive samples in nasopharyngeal carcinoma

Aktive Filter

Suchergebnisse filtern